Dr. Tarek A. Helmy, MD

Dr. Helmy practices at Saint Francis Medical Group in Hartford, Connecticut.

Dr. Helmy's NPI, 1851306641, was assigned on July 30, 2006. Dr. Helmy graduated from Cairo University School of Medicine in 1991. Dr. Helmy holds Louisiana license 323668.

Dr. Helmy's primary practice is Saint Francis Medical Group, at 1000 Asylum Ave, Hartford, CT 06105 in Capitol County. The practice phone is (860) 714-1325.

Dr. Helmy's primary practice is Saint Francis Medical Group in Hartford, Connecticut. Dr. Helmy is also affiliated with Saint Francis Hospital. The medical group on file is Trinity Health Of New England Medical Group. Dmand AI also links Dr. Helmy to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Helmy practices, 2 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Helmy's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dmand AI has Dr. Helmy's licenses on file in 3 states: Louisiana, Georgia and Ohio.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiac catheterization, chronic hypertension, coronary artery disease, heart failure and pacemaker or defibrillator implantation among the conditions Dr. Helmy treats.

CMS data shows 125 Medicare services from Dr. Helmy across 4 procedure codes in 2024, for 93 Medicare patients. Medicare paid $10,742 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 93 Medicare patients who saw Dr. Helmy in 2024. The largest group is 65 to 74, with 45 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 44% are also on Medicaid. Their average risk score is 2.46, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Helmy's median patient age at 74, with 50% women.

In 2024, Dr. Helmy wrote 70 Medicare Part D claims for 16 patients. 97% of them were for generic drugs. CMS names the drug for 37 of them, across 2 drugs with 11 or more claims each, at $217 in total drug cost. In 2023, CMS named 34 claims across 2 drugs.

Dr. Helmy accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 79 papers to Dr. Helmy, published from 2005 to 2025. 2024 was the busiest year, with 6. The most frequent topics are Coronary Angiography, Cardiac Catheterization and Coronary Artery Disease. Dr. Helmy has published most often in Catheter Cardiovasc Interv. Dr. Helmy's most frequent co-authors are Mohamed A. Effat, MD, Imran Arif, MD and Shafaqat Ali, MD.

Dmand AI links Dr. Helmy to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Coronary Artery Disease and Coronary Disease.

CMS Open Payments shows 443 general payments to Dr. Helmy from 38 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 42% of the total. Medtronic, Inc. paid the most, $26,993.

Dmand AI lists 2 awards for Dr. Helmy, most recently ACC Fellow in 2012.

Dr. Helmy graduated from Cairo University School of Medicine in 1991.

Dr. Helmy is in network with 10 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.